Published in AIDS Weekly, October 8th, 2007
"This study aimed to evaluate the cost-effectiveness of HAART therapy. HAART-associated improvement in survival was obtained by analyzing the follow-up data of all HIV-positive patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.